EK
EKSO
ChronoScale Corp
No data for this timeframe.
Vol
Inst. Holders3 funds
Inst. Value$307.0K
Inst. Activity0 buys / 1 sells
Insider Activity9B / 0S
Insider Net $$756.1K
SEC Reports3
Recent Activity
May 16, 2026
SEC
Five Form 3 filings were submitted on May 15, 2026, by William M. Clancy, Wes Cummins, Douglas S. Miller, Richard N. Not
3 — Impact 3/10
May 4, 2026
SEC
Ekso Bionics is consummating a business combination with subsidiaries of Applied Digital Corporation, concurrently closi
8-K — Impact 7/10
Mar 20, 2026
SEC
Two C-suite executives at Ekso Bionics — the COO and CFO — each purchased 1,308 shares in the open market at $11.85 per
CLUSTER — Impact 6/10
Mar 16, 2026
Insider
Wong Jerome bought 1,308 shares
Chief Financial Officer @ $11.85 ($15.5K)
Mar 16, 2026
Insider
Jones Jason C bought 1,308 shares
Chief Operating Officer @ $11.85 ($15.5K)
Feb 19, 2026
Insider
ASHER DANIEL bought 15,540 shares
10%+ Owner @ $12.30 ($191.2K)
Inst.
BANK OF AMERICA CORP — TRIM
80 shares ($692.00)
Inst.
VANGUARD GROUP INC — DOUBLED
35,451 shares ($181.9K)
Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$9.50 (Dec 2025)
Current $11.80
Low $9.50
Median $9.50
High $9.50
1 analysts
$9.50
$9.50
Analyst Ratings
2Strong Buy
4Buy
2Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Dec 31, 2025 | HC Wainwright & Co. | DOWNGRADE | Buy → Neutral |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.06 ▲ +60.0% | $-0.06 — $-0.06 | 95% YoY | 1 |
| Next Q | $-0.02 ▲ +66.7% | $-0.02 — $-0.02 | 96% YoY | 1 |
| Current FY | $-0.15 ▲ +65.5% | $-0.15 — $-0.15 | 97% YoY | 1 |
| Next FY | $-0.07 | $-0.07 — $-0.07 | 53% YoY | 1 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $306.3K | DOUBLED |
| BANK OF AMERICA CORP | $692.00 | TRIM |
| MORGAN STANLEY | $26.00 | NEAR_EXIT |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 16, 2026 | Wong Jerome | BUY | $15.5K |
| Mar 16, 2026 | Jones Jason | BUY | $15.5K |
| Feb 19, 2026 | ASHER DANIEL | BUY | $191.2K |
| Feb 13, 2026 | ASHER DANIEL | BUY | $101.4K |
| Feb 12, 2026 | ASHER DANIEL | BUY | $81.8K |
3 institutional holders with $307.0K total value (35,534 shares) as of 2025-Q4. Top holders: VANGUARD, BANK, MORGAN. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 35,451 | $306.3K | 99.8% | DOUBLED +196.3% |
| 2 | BANK OF AMERICA CORP /DE/ | 80 | $692.00 | 0.2% | TRIM -40.7% |
| 3 | MORGAN STANLEY | 3 | $26.00 | 0.0% | NEAR_EXIT -95.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | TRIM | 135 | 80 | -40.7% | $692.00 | 2025-Q4 |
| VANGUARD GROUP INC | DOUBLED | 11,964 | 35,451 | +196.3% | $181.9K | 2025-Q3 |
| UBS Group AG | DOUBLED | 6 | 32,462 | +540933.3% | $166.5K | 2025-Q3 |
| MORGAN STANLEY | NEAR_EXIT | 69 | 3 | -95.7% | $15.00 | 2025-Q3 |
| VANGUARD GROUP INC | NEW | — | 11,964 | — | $39.4K | 2025-Q2 |
| VANGUARD GROUP INC | EXIT | 593,648 | 0 | -100.0% | $0.00 | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 82,116 | 0 | -100.0% | $0.00 | 2025-Q2 |
| CITADEL ADVISORS LLC | NEW | — | 179,947 | — | $72.5K | 2025-Q1 |
| UBS Group AG | DOUBLED | 154 | 1,439 | +834.4% | $580.00 | 2025-Q1 |
| MORGAN STANLEY | TRIM | 129 | 62 | -51.9% | $72.00 | 2024-Q3 |
3 unique insiders with 9 transactions. Net insider value: $756.1K ($756.1K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Wong Jerome | Chief Financial Officer | BUY | 1,308 | $11.85 | $15.5K |
| Mar 16, 2026 | Jones Jason C | Chief Operating Officer | BUY | 1,308 | $11.85 | $15.5K |
| Feb 19, 2026 | ASHER DANIEL | 10%+ Owner | BUY | 15,540 | $12.30 | $191.2K |
| Feb 13, 2026 | ASHER DANIEL | 10%+ Owner | BUY | 11,092 | $9.14 | $101.4K |
| Feb 12, 2026 | ASHER DANIEL | 10%+ Owner | BUY | 8,908 | $9.18 | $81.8K |
| Feb 11, 2026 | ASHER DANIEL | 10%+ Owner | BUY | 20,611 | $9.69 | $199.8K |
| Feb 10, 2026 | ASHER DANIEL | 10%+ Owner | BUY | 10,200 | $9.92 | $101.2K |
| Feb 9, 2026 | ASHER DANIEL | 10%+ Owner | BUY | 4,800 | $9.96 | $47.8K |
| Feb 6, 2026 | ASHER DANIEL | 10%+ Owner | BUY | 194 | $9.86 | $1.9K |
3 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 5.3/10.
NEUTRAL
3
3/10
Five Form 3 filings were submitted on May 15, 2026, by William M. Clancy, Wes Cummins, Douglas S. Mi
May 16, 2026
BULLISH
8-K
7/10
Ekso Bionics is consummating a business combination with subsidiaries of Applied Digital Corporation
May 4, 2026
BULLISH
CLUSTER
6/10
Two C-suite executives at Ekso Bionics — the COO and CFO — each purchased 1,308 shares in the open m
Mar 20, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Dec 2025): 75% buy across 8 analysts — 2 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$9.50 mean target (Dec 2025)
$9.50 Low
$9.50 High
| Metric | Value |
|---|---|
| Current Price | $11.80 |
| Target Low | $9.50 |
| Target Mean | $9.50 |
| Target Median | $9.50 |
| Target High | $9.50 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.06 | $-0.06 | $-0.06 | 95.2% | +60.0% | 1↑ 0↓ | $0.0B | 21.5% | 1 |
| Next Q 2026-09-30 |
$-0.02 | $-0.02 | $-0.02 | 96.3% | +66.7% | 1↑ 0↓ | $0.0B | 27.8% | 1 |
| Current FY 2026-12-31 |
$-0.15 | $-0.15 | $-0.15 | 96.9% | +65.5% | 1↑ 0↓ | $0.0B | 51.4% | 1 |
| Next FY 2027-12-31 |
$-0.07 | $-0.07 | $-0.07 | 53.3% | +0.0% | 0↑ 1↓ | $0.0B | 25.9% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.060 | |
| 7d ago | $-0.150 | +0.090 |
| 30d ago | $-0.150 | +0.090 |
| 60d ago | $-0.150 | +0.090 |
| 90d ago | $-0.150 | +0.090 |
1 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Dec 31, 2025 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Apr 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Mar 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Feb 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Jan 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 6, 2026
other
ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth
<p align="justify">DALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN), an accelerated compute platform purpose-built to
May 4, 2026
earnings_calendar
EKSO Q1 2026 Earnings Scheduled — 2026-05-04